Patient Guide: Pimavanserin vs. Quetiapine for Treatment of Parkinson's Psychosis

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 24 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT04373317
Status: 🟢 Enrolling Now
Condition: Parkinson's Disease Psychosis
Phase: PHASE4

Where You Can Participate

This study is available at 24 locations across the country.

Top locations include:
  • • Tucson, Arizona
  • • Loma Linda, California
  • • Palo Alto, California
  • • And 21 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

Pimavanserin vs. Quetiapine for Treatment of Parkinson's Psychosis - Join Clinical Trial NCTNCT04373317

How to Join This Clinical Trial - NCTNCT04373317

Learn how to participate in this PHASE4 trial studying an investigational therapy for Parkinson's Disease Psychosis. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Parkinson's Disease Psychosis. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Parkinson's Disease Psychosis
Treatment Being Tested
Investigational treatment
Study Phase
PHASE4 - Research study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT04373317 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 24 locations. Find a study site near you:

Clinical Research Site

Tucson, Arizona 85723-0001 - United States

Status: TERMINATED

Clinical Research Site

Loma Linda, California 92357-1000 - United States

Status: RECRUITING

Clinical Research Site

Palo Alto, California 94304-1207 - United States

Status: RECRUITING

Clinical Research Site

San Francisco, California 94121-1563 - United States

Status: RECRUITING

Clinical Research Site

West Los Angeles, California 90073-1003 - United States

Status: TERMINATED

Clinical Research Site

Aurora, Colorado 80045 - United States

Status: RECRUITING

Clinical Research Site

Gainesville, Florida 32608-1135 - United States

Status: RECRUITING

Clinical Research Site

Hines, Illinois 60141-5000 - United States

Status: RECRUITING

Clinical Research Site

Lexington, Kentucky 40502-2235 - United States

Status: TERMINATED

Clinical Research Site

Ann Arbor, Michigan 48105 - United States

Status: RECRUITING

And 14 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE4 clinical trial for Parkinson's Disease Psychosis:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships